Clinical Trial of CAM2038, Long-acting Subcutaneous Buprenorphine Injections for Treatment of Patients With Opioid Dependence

Clinical trial NCT02651584 · COMPLETED

Trial details

NCT number: NCT02651584
Sponsor: Braeburn Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Opioid Use Disorders

Start date: 2015-12-01
Primary completion: 2016-10-01
Enrollment: 428

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.